Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Acquisition of CompliSpace

9th Nov 2021 07:00

RNS Number : 7742R
Ideagen PLC
09 November 2021
 

9th November 2021

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Acquisition of CompliSpace

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, is pleased to announce the acquisition of Compliance Technology Holdings Pty Ltd t/a CompliSpace ("CompliSpace") for an upfront consideration of AUD$105 million (c. £57.7 million) plus a deferred conditional earnout payment of up to AUD$5 million (c. £2.7 million).

 

Founded in 2007, CompliSpace is a fast-growing provider of SaaS-enabled governance, risk and compliance (GRC) management solutions to private and public sector customers. CompliSpace's principal focus is in the education and social care sectors where Ideagen sees globally compelling structural growth tailwinds. CompliSpace serves more than 950 clients in Australia including more than 730 schools and 135 aged care facilities across the country.

 

CompliSpace's proprietary software platform simplifies complex and time-consuming GRC tasks covering Policy Management, Learning and Assurance by mapping a company's policies and procedures to regulatory obligations, supported by online learning, and automated workflow and reporting. This helps customers focus on their core purpose, centralising information in an easily navigable manner allowing for better overall governance.

 

CompliSpace currently has annualised proforma revenues of approximately AUD$19.0 million (c. £10.4 million) of which 88% is recurring and has grown by approximately 20% over the last twelve months. The earn-out is payable dependent on approximately 20% per annum recurring revenue growth over the next 24 months to reach ARR of AUD$23.5 million (c. £12.8 million) by the second anniversary of acquisition. Ideagen also expects to benefit from operational leverages such that CompliSpace will achieve EBITDA margins comparable to the Group's in the first full year of ownership to April 2023.

 

CompliSpace's CEO, David Griffiths, will join Ideagen as regional SVP and will, together with his senior leadership team, support the integration and future growth strategy. The CompliSpace product will be integrated in to the wider Ideagen common services architecture providing future upsell opportunities.

 

CompliSpace recorded revenue of AUD$15.4 million (c. £8.4 million) and a loss before tax of AUD$3.6 million (c. £2.0 million) for the year to 30 June 2021 with net assets of AUD$11.6 million (c. £6.4 million) at that date. The acquisition will be funded from the Group's existing cash and debt resources.

 

Ideagen looks forward to providing an update on trading in the first six months to 31 October 2021 in mid-November 2021 and will be hosting a capital markets day on 30 November 2021.

 

Ben Dorks, CEO of Ideagen, commented:

"The acquisition of CompliSpace delivers three clear strategic objectives for Ideagen - a complementary commercial offering with a compelling growth opportunity, a strong footprint in a new geography, and enhances our ARR.

We see a significant opportunity to leverage CompliSpace's Australian footprint with our existing product suite, whilst also expanding its customer base into Europe and North America - in line with our strategy to grow both our geographical and sector expertise."

We are very excited to add CompliSpace to our business. The acquisition reinforces our strategy of supporting customers operating in highly regulated environments with high quality software solutions across a range of platforms.

We look forward to providing further information on the Group's performance and prospects in the forthcoming trading update."

This announcement assumes an AUD:GBP exchange rate of $1.83:£1.00.

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer

Emma Hayes, Chief Financial Officer

 

finnCap Ltd

020 7220 0500

Henrik Persson / James Thompson (Nomad)

Alice Lane (ECM)

 

Canaccord Genuity Limited (Joint Broker)

Simon Bridges

Georgina McCooke

 

 

020 7523 8000

 

Numis (Joint Broker)

0207 260 1267

Simon Willis

Joshua Hughes

Tejas Padalkar

FTI Consulting

020 3727 1000

Jamie Ricketts

[email protected]

Dwight Burden

Valerija Cymbal

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

Ideagen is a leader in the $30 billion GRC software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance. Ideagen has made twenty acquisitions to build its market leadership.

More than 6000 organisations use Ideagen's software, including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of leading pharmaceutical firms.

Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.

With over 700 employees Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, EU, US, Middle East and South East Asia. For further information please visit www.ideagen.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQZZMGMVLMGMZG

Related Shares:

IDEA.L
FTSE 100 Latest
Value8,275.66
Change0.00